Insider Selling: Core Molding Technologies, Inc. (NYSEAMERICAN:CMT) CEO Sells 14,171 Shares of Stock

Core Molding Technologies, Inc. (NYSEAMERICAN:CMTGet Free Report) CEO David L. Duvall sold 14,171 shares of the stock in a transaction dated Tuesday, December 24th. The stock was sold at an average price of $16.54, for a total transaction of $234,388.34. Following the sale, the chief executive officer now directly owns 243,341 shares in the company, valued at $4,024,860.14. This represents a 5.50 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Core Molding Technologies Stock Down 0.4 %

Shares of CMT opened at $16.51 on Friday. The company has a market cap of $147.93 million, a P/E ratio of 9.33 and a beta of 1.75. The company has a current ratio of 2.41, a quick ratio of 1.98 and a debt-to-equity ratio of 0.14. Core Molding Technologies, Inc. has a fifty-two week low of $14.64 and a fifty-two week high of $21.00.

Core Molding Technologies (NYSEAMERICAN:CMTGet Free Report) last issued its earnings results on Tuesday, November 5th. The industrial products company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.13. Core Molding Technologies had a net margin of 4.95% and a return on equity of 10.76%. The firm had revenue of $72.99 million for the quarter, compared to analysts’ expectations of $71.57 million. On average, equities research analysts forecast that Core Molding Technologies, Inc. will post 1.64 EPS for the current fiscal year.

Institutional Investors Weigh In On Core Molding Technologies

Several institutional investors have recently modified their holdings of CMT. Ashton Thomas Private Wealth LLC acquired a new stake in Core Molding Technologies in the second quarter valued at $27,000. LSV Asset Management purchased a new position in shares of Core Molding Technologies in the 2nd quarter valued at about $36,000. MetLife Investment Management LLC raised its position in shares of Core Molding Technologies by 131.0% during the 3rd quarter. MetLife Investment Management LLC now owns 4,460 shares of the industrial products company’s stock worth $77,000 after acquiring an additional 2,529 shares in the last quarter. Barclays PLC raised its position in shares of Core Molding Technologies by 278.9% during the 3rd quarter. Barclays PLC now owns 9,942 shares of the industrial products company’s stock worth $172,000 after acquiring an additional 7,318 shares in the last quarter. Finally, Rhumbline Advisers lifted its stake in Core Molding Technologies by 8.4% during the second quarter. Rhumbline Advisers now owns 11,174 shares of the industrial products company’s stock worth $178,000 after purchasing an additional 866 shares during the last quarter. 58.79% of the stock is owned by hedge funds and other institutional investors.

Core Molding Technologies Company Profile

(Get Free Report)

Core Molding Technologies, Inc, together with its subsidiaries, operates as a molder of thermoplastic and thermoset structural products. The company offers a range of manufacturing processes that include compression molding of sheet molding compound, resin transfer molding, liquid molding of dicyclopentadiene, spray-up and hand-lay-up, direct long-fiber thermoplastics, and structural foam and structural web injection molding.

See Also

Insider Buying and Selling by Quarter for Core Molding Technologies (NYSEAMERICAN:CMT)

Receive News & Ratings for Core Molding Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Molding Technologies and related companies with MarketBeat.com's FREE daily email newsletter.